- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
Australian vaccine manufacturer CSL announced that it has started producing University of Oxford and AstraZeneca candidate vaccine on 9 November. The production of the Oxford vaccine comes before it has been approved by the Therapeutic Goods Administration (TGA).
The New Daily also states that the vaccine candidate developed by the University of Queensland (UQ) is also in production by CSL. The UQ vaccine is undergoing Phase 1 trials. Australia had previously confirmed an order for 51 million doses of the UQ vaccine and 34 million of the Oxford candidate.Australia has also recently announced deals to purchase the Novavax and Pfizer / BioNTech COVID vaccines.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape
Additional data provided by
English
Japanese
